These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16770858)

  • 21. Medical research oversight from the corporate governance perspective: comparing institutional review boards and corporate boards.
    Saver RS
    William Mary Law Rev; 2004 Nov; 46(2):619-730. PubMed ID: 17167924
    [No Abstract]   [Full Text] [Related]  

  • 22. Case study: agency says institutional review board (IRB) failed to warn subjects of significant problems.
    Maloney DM
    Hum Res Rep; 2006 Mar; 21(3):6-7. PubMed ID: 16789303
    [No Abstract]   [Full Text] [Related]  

  • 23. Case study: research subject says institutional review board (IRB) was no help.
    Maloney DM
    Hum Res Rep; 2006 Jan; 21(1):7. PubMed ID: 16789306
    [No Abstract]   [Full Text] [Related]  

  • 24. Case study: institutional review board (IRB) did not know about subject problem until after study.
    Maloney DM
    Hum Res Rep; 2006 May; 21(5):6-7. PubMed ID: 16832916
    [No Abstract]   [Full Text] [Related]  

  • 25. Protection of health research participants in the United States: a review of two cases.
    Douglass A; Crampton P
    N Z Bioeth J; 2004 Jun; 5(2):6-12. PubMed ID: 15597497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethical oversight of research in developing countries.
    Kass N; Dawson L; Loyo-Berrios NI
    IRB; 2003; 25(2):1-10. PubMed ID: 12833901
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical research regulation: challenges to the institutional review board system.
    Straight TM
    Clin Dermatol; 2009; 27(4):375-83. PubMed ID: 19539166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resource and needs of research ethics committees in Africa: preparations for HIV vaccine trials.
    Milford C; Wassenaar D; Slack C
    IRB; 2006; 28(2):1-9. PubMed ID: 16770882
    [No Abstract]   [Full Text] [Related]  

  • 29. Financial conflicts of interest and protection of human research subjects.
    Maloney DM
    Hum Res Rep; 2004 Jun; 19(6):1-2. PubMed ID: 15462034
    [No Abstract]   [Full Text] [Related]  

  • 30. Status of national research bioethics committees in the WHO African region.
    Kirigia JM; Wambebe C; Baba-Moussa A
    BMC Med Ethics; 2005 Oct; 6():E10. PubMed ID: 16242014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Informed consent for research on stored blood and tissue samples: a survey of institutional review board practices.
    White MT; Gamm J
    Account Res; 2002; 9(1):1-16. PubMed ID: 12705242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biotech and pharma face more costly clinical trials.
    Brower V
    Nat Biotechnol; 1998 Aug; 16(8):714. PubMed ID: 9702762
    [No Abstract]   [Full Text] [Related]  

  • 33. Should society allow research ethics boards to be run as for-profit enterprises?
    Emanuel EJ; Lemmens T; Elliot C
    PLoS Med; 2006 Jul; 3(7):e309. PubMed ID: 16848618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The need to understand IRB deliberations.
    Candilis PJ; Lidz CW; Arnold RM
    IRB; 2006; 28(1):1-5. PubMed ID: 16680872
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of central institutional review boards for multicenter clinical trials in the United States: a review of the literature.
    Check DK; Weinfurt KP; Dombeck CB; Kramer JM; Flynn KE
    Clin Trials; 2013 Aug; 10(4):560-7. PubMed ID: 23666951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. University's Multiple Project Assurance (MPA) could be renewed for only short periods of time.
    Maloney DM
    Hum Res Rep; 2000 Jul; 15(7):5-6. PubMed ID: 12199226
    [No Abstract]   [Full Text] [Related]  

  • 37. Ontario Cancer Research Ethics Board: lessons learned from developing a multicenter regional institutional review board.
    Saginur R; Dent SF; Schwartz L; Heslegrave R; Stacey S; Manzo J
    J Clin Oncol; 2008 Mar; 26(9):1479-82. PubMed ID: 18349399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Death in gene therapy trial raises questions about private IRBs.
    Ledford H
    Nat Biotechnol; 2007 Oct; 25(10):1067. PubMed ID: 17921976
    [No Abstract]   [Full Text] [Related]  

  • 39. Recurrent issues in the review of medical research on human subjects.
    Moore DL
    Albany Law J Sci Technol; 1991; 1():1-33. PubMed ID: 16296123
    [No Abstract]   [Full Text] [Related]  

  • 40. Making research ethics review work in Zimbabwe--the case for investment in local capacity.
    Mielke J; Ndebele P
    Cent Afr J Med; 2004; 50(11-12):115-9. PubMed ID: 16615661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.